Topiramate for the Prophylactic Treatment of Cyclic Vomiting Syndrome in Children
Public ClinicalTrials.gov record NCT00286988. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the effectiveness, tolerability and safety of oral topiramate for the preventative management of Cyclic Vomiting Syndrome. It is believed that topiramate will decrease the frequency, duration and severity of attacks experienced by children and adolescents with Cyclic Vomiting Syndrome.
Study identification
- NCT ID
- NCT00286988
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2006
- Primary completion
- Apr 30, 2007
- Completion
- May 31, 2007
- Last update posted
- Jan 5, 2011
2006 – 2007
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Monarch Medical Research - Child and Adolescent Neurology | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Vomiting trials
Other public records listing Vomiting. Sorted by last update posted; newest first. Not a recommendation.
- NCT04250844: Use of Intrapyloric Botulinum Injections in Children Active, not recruiting
- NCT06740812: Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide Not yet recruiting
- NCT06382012: Antiemetic Fosaprepitant To Remedy Nausea and Vomiting Recruiting
- NCT06464926: Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE) Recruiting
- NCT07169851: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer Recruiting
- NCT06532734: Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00286988, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2011 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00286988 live on ClinicalTrials.gov.